Two claims, two devices, two and a half years apart.
Muscle, February 2017: "Improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen." That is the plain EmSculpt claim, and it is about muscle only.
Fat, December 2019, on the NEO: "Non-invasive lipolysis (breakdown of fat) of the abdomen" and "Reduction in circumference of the abdomen," originally for skin types I to III and widened to I to VI in July 2021. Lipolysis means breakdown of fat. That claim is filed under the regulation for heat-based devices, not the muscle-stimulator regulation, because it is the radiofrequency doing the work.
A 510(k) clearance is a finding of substantial equivalence to a device already on the market. It is not proof that the device produces a result: The 2017 abdominal filing is explicit that its "substantial equivalence determination is not based on clinical testing" and rested on comparing technical characteristics with the predicate device.
A note on attribution: BTL files with FDA under model numbers rather than trade names, and FDA does not publish a link between a brand name and a clearance number. The indication wording above is quoted exactly. Which brand it belongs to is an inference from device descriptions and marketing, including on this page.
Here is what has actually been measured on the abdomen, in order of how often it gets quoted.
Twenty-two people, MRI, four sessions: At two months: subcutaneous fat down 18.6 per cent, rectus abdominis thickness up 15.4 per cent, separation between the two halves of the abdominal muscle down 10.4 per cent, all at p less than 0.0001. Circumference below the navel down 3.8 cm. Weight change was minus 0.5 lb and not statistically significant — which is the study doing the right thing and showing the result was not weight loss. Open-label, single-arm, no control. Its lead author declares in other papers that he is a medical advisor to the manufacturer.
Thirty-three people, ultrasound, four standardised measuring points: Fat down 19.0 per cent at one month and 23.3 per cent at three months.
Twenty-two people, CT, eight sessions: Fat down 17.5 per cent, which is 3.1 mm. Rectus abdominis up 14.8 per cent, which is 1.5 mm. Waist down 3.9 cm. This study also produced the actual basis for the standard four-session course: it concluded that "4 treatments as the ideal protocol delivering 86 per cent of the observed improvement."
Twenty-one people rescanned at an average of 333 days: Fat down 14.63 per cent, which is about 3 mm. Muscle up 19.05 per cent, which is about 1.9 mm. Muscle separation down 10.46 per cent. Not related to weight change. This is the longest published follow-up in the field, and its own authors say the durability "needs to be verified by continuing follow-up of this group and by further studies."
EmSculpt NEO, 41 people, MRI, three sessions: At three months: muscle up 26.1 per cent, fat down 30.8 per cent, abdominal separation down 18.8 per cent, waist down 5.87 cm. Maintained at six months.
One genuinely independent dataset exists: A six-person MRI pilot at a Taiwanese university hospital, with a declared absence of competing interests, measured rectus abdominis by three-dimensional volume rather than thickness. Volume rose between 4.0 and 21.1 per cent at three months — but thickness measurements were inconsistent and some decreased, which is a useful warning about how much a single measured thickness can wander.
Almost every other study here was written by declared advisors to the manufacturer. An independent 2023 review put it plainly: "Almost all studies were authored by medical advisors for the device manufacturer." For the NEO specifically, a 2025 review found all seven studies were authored by manufacturer medical advisors.
This pairing is everywhere on clinic websites, usually attributed to a journal without a study name, a sample size or a year.
No published study reports 16 per cent muscle growth and 19 per cent fat reduction together: The closest single source is the 22-person MRI study above: plus 15.4 per cent muscle, minus 18.6 per cent fat. Rounded, those become 16 and 19. Separately, a 33-person ultrasound study reported 19.0 per cent fat reduction at one month, and a 20-person ultrasound study reported biceps up 16.13 per cent — a different muscle in a different limb.
The version of this claim that goes further is worse. Clinic pages routinely add "16 per cent fat reduction in the buttocks." No study reports that. The claim is contradicted by the actual gluteal MRI data: the one MRI study of gluteal tissue found gluteal fat "insignificantly affected," and a later full-body MRI series described the change in buttock fat as "negligible."
For what it is worth, the manufacturer's own current material does not use 16 and 19 either. It quotes NEO figures of 25 per cent muscle growth and 30 per cent fat reduction, which round from the 41-person NEO study above. Those are the manufacturer's marketing numbers from open-label studies written by its own advisors.
Across the whole electromagnetic body-contouring literature there is exactly one randomised, sham-controlled trial: Seventy-two people: 48 active, 24 sham with the device set to 5 per cent intensity. Three weekly abdominal treatments with the NEO, measured by ultrasound. At one month the active group showed fat down 20.5 per cent (4.8 mm) and rectus abdominis up 21.5 per cent (2.0 mm). At three months, fat down 28.3 per cent (7.6 mm) and muscle up 24.2 per cent (2.3 mm), maintained at six months. The sham group showed no significant change. The paper carries no conflict statement; two of its three authors declare manufacturer advisory roles in other papers.
Set against that, the independent syntheses:
A 2023 review of 14 studies: 1 of 14 had a sham group. Pooled effect 5.5 mm less fat and 2.2 mm more muscle. Muscle separation improved by 2.9 mm at p equals 0.19 — not statistically significant. Its verdict: "the evidence for efficacy is tenuous. Measured treatment effects are very small (less than 5 mm)."
The same reviewer on mechanism: "muscle hypertrophy is not known to occur acutely after exercise; muscle swelling likely accounts for an early increment in muscle thickness. Any improvement in the diastasis recti is likely fictitious."
A 2024 systematic review of 15 studies: "No studies reported weight change before and after treatment." That is the most damaging single line in this literature. If you never weigh anyone, you cannot separate a treatment effect from three pounds lost.
A 2025 review of the seven NEO studies: fat down 8.0 mm and muscle up 5.5 mm on average, all seven by manufacturer advisors, and "measured changes were likely within the margin of error."
That reviewer is a practising liposuction surgeon whose conclusions consistently favour surgery, which is a structural interest worth naming even though he declares no industry money. His methodological points about photographs, MRI slice level and conflict of interest stand on their own.
No published study measures anything in crunches: There is no protocol, no equivalence calculation and no paper behind the figure. Contraction counts appear nowhere in the clearance documents, which contain no session count or schedule at all.
Where the phrase does appear in an official record is in FDA's post-market complaint database. A 2025 report from a purchaser states the device was sold with the claim that it equals "20,000 crunches in 30 mins," that "the machine did not work as claimed," and that the claim was off-label. That is a single voluntary complaint, not a finding, and that database has no denominator — you cannot turn reports into a rate of anything. But it is the only place the number appears in a public record, and it appears there as an allegation about a sales claim.
Treat "20,000 crunches" as advertising language. What the device does is produce involuntary muscle contractions stronger than you can produce voluntarily, because the magnetic field depolarises motor nerves directly. That is a real mechanism. The crunch number is not a measurement of it.
The abdomen responds to more non-treatment variables than any other area.
Pelvic tilt: Rotating the pelvis backwards flattens the lower abdomen instantly. Standing tall versus relaxed changes the abdominal profile by more than any of these devices do.
Breath phase: Held in versus relaxed.
Time of day and meal state: Abdominal circumference at 8am is not the same number as at 8pm.
Weight: In one cryolipolysis inner-thigh study from a neighbouring technology, 45 people were treated and only the 42 who stayed within 5 lb of their baseline weight were analysed — an admission that a 5 lb swing swamps the effect being measured. The HIFEM literature did not record weight at all.
Light direction, tan and garment: Raking light drops shadow into the midline and reads as definition. Even skin tone reads as smoother. A different waistband height changes where the abdomen appears to end.
Time since exercise: Muscle swells after work, which is the basis of the argument that the early "muscle thickness" gains in these studies are swelling.
Two things are worth knowing about how imaging itself gets used. MRI is the most accurate method here and the most abusable: if the post-treatment slice is taken a couple of centimetres higher or lower than the baseline slice, almost any result can be produced, and one review notes exactly that problem in these studies. And in the FDA study behind the abdominal fat clearance, the blinded photograph identification rate was 76.19 per cent — meaning independent reviewers correctly picked the before photo three times in four. That is a detection threshold, not a size. It tells you a change is visible; it tells you nothing about how big it is.
That same FDA summary gives the cleanest independent restatement of the abdominal fat result: 44 enrolled and 42 completing, three treatments, abdominal circumference down 3.2 cm plus or minus 1.64 cm at three months, 88.1 per cent achieving at least 1.5 cm, and ultrasound fat reduction of 29.8 per cent.
Which device produced them, EmSculpt or EmSculpt NEO?: The fat and circumference claims exist only for the NEO.
Were these patients weighed?: Ask for your own weight to be recorded at every visit.
Are the two photographs standardised?: Same distance, lens, light, stance, breath, waistband, time of day.
Look at the untreated parts of the frame: Shoulders, arms, collarbones. If those changed too, the treatment did not cause the change — an issue documented in this literature's own photographs.
If separated abdominal muscles are your concern, know that the reported improvement is roughly 2 mm on imaging, that one independent review calls it likely artefact, and that surgical repair is a different thing entirely.
And the frame around all of it, from the regulator: FDA states that non-invasive body contouring "does not treat obesity or improve your health" and "will not result in weight loss."
Tell the clinic in advance about an implanted electronic device — pacemaker, defibrillator, nerve stimulator — or any metal implant in or near the abdomen, including surgical mesh, plates or screws. These are contraindications for powered muscle stimulators as a class. Say if you have a cancer diagnosis involving the area.
Ask to be weighed at the first visit and every follow-up, and ask for it to be written down. It is the cheapest way to make your own before-and-after mean something.
Ask for photographs taken to a fixed protocol, and ask what the protocol is. Ask for waist circumference measured at a marked, recorded landmark rather than wherever the tape lands.
If you have been told this will repair separated abdominal muscles, ask what measurement will be used and what the expected change is in millimetres.
Fever together with spreading redness, warmth or pus at the treated area. These are signs of a spreading infection and need urgent same-day care.
A blister or open, weeping burn on the treated skin. One report in FDA's post-market database describes a 2 cm open erosion in the lower abdomen after treatment with the NEO.
Extreme tenderness and swelling develop in the treated abdomen. The same post-market report describes a suspected abdominal haematoma that took about 10 weeks to resolve.
A firm lump appears in the treated area and does not settle.
Soreness keeps increasing after about day three rather than easing. Aching like the day after hard exercise is the commonly reported after-effect; roughly a quarter of subjects in one FDA-summarised study reported it, and it settles.
The skin over the treated area stays red, darkens, or feels numb for more than a few days.
You were sold abdominal fat reduction and the device turns out to be plain EmSculpt rather than the NEO.